Cargando…

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020

We evaluated SARS-CoV-2 RNA and neutralising antibodies in blood donors (BD) residing in the Lodi Red Zone, Italy. Of 390 BDs recruited after 20 February 2020 − when the first COVID-19 case in Lombardy was identified, 91 (23%) aged 19–70 years were antibody positive. Viral RNA was detected in an add...

Descripción completa

Detalles Bibliográficos
Autores principales:	Percivalle, Elena, Cambiè, Giuseppe, Cassaniti, Irene, Nepita, Edoardo Vecchio, Maserati, Roberta, Ferrari, Alessandro, Di Martino, Raffaella, Isernia, Paola, Mojoli, Francesco, Bruno, Raffaele, Tirani, Marcello, Cereda, Danilo, Nicora, Carlo, Lombardo, Massimo, Baldanti, Fausto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2020
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315724/ https://www.ncbi.nlm.nih.gov/pubmed/32583766 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.24.2001031

Ejemplares similares

Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area
por: Cassaniti, Irene, et al.
Publicado: (2021)

Thirteen Years of Phleboviruses Circulation in Lombardy, a Northern Italy Region
por: Percivalle, Elena, et al.
Publicado: (2021)

Authors’ response: COVID-19: how accurate are seroprevalence studies?
por: Cassaniti, Irene, et al.
Publicado: (2020)

Preliminary results on an autochthonous dengue outbreak in Lombardy Region, Italy, August 2023
por: Cassaniti, Irene, et al.
Publicado: (2023)

Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020
por: Guzzetta, Giorgio, et al.
Publicado: (2020)

Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016
por: Zavattoni, Maurizio, et al.
Publicado: (2016)

Asymptomatic infection with clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) in carnivore pets, Italy, April 2023
por: Moreno, Ana, et al.
Publicado: (2023)

Swine influenza A (H1N1) virus (SIV) infection requiring extracorporeal life support in an immunocompetent adult patient with indirect exposure to pigs, Italy, October 2016
por: Rovida, Francesca, et al.
Publicado: (2017)

The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
por: Zuckerman, Neta, et al.
Publicado: (2021)

SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020
por: Lumley, Sheila F, et al.
Publicado: (2020)

Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020
por: Poletti, Piero, et al.
Publicado: (2020)

The early phase of the COVID-19 epidemic in Lombardy, Italy
por: Cereda, Danilo, et al.
Publicado: (2021)

Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020
por: Mehew, Jennifer, et al.
Publicado: (2020)

West Nile or Usutu Virus? A Three-Year Follow-Up of Humoral and Cellular Response in a Group of Asymptomatic Blood Donors
por: Percivalle, Elena, et al.
Publicado: (2020)

Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020
por: Colaneri, Marta, et al.
Publicado: (2020)

Fulminant echovirus 11 hepatitis in male non-identical twins in northern Italy, April 2023
por: Piralla, Antonio, et al.
Publicado: (2023)

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
por: Nguyen, Dung, et al.
Publicado: (2021)

Spread of multiple SARS‐CoV‐2 lineages April‐August 2020 anticipated the second pandemic wave in Lombardy (Italy)
por: Tallarita, Monica, et al.
Publicado: (2022)

SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: a preliminary evaluation
por: Percivalle, E., et al.
Publicado: (2021)

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
por: Paolucci, Stefania, et al.
Publicado: (2021)

Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol
por: Perotti, Cesare, et al.
Publicado: (2020)

Expanding Usutu virus circulation in Italy: detection in the Lazio region, central Italy, 2017 to 2018
por: Carletti, Fabrizio, et al.
Publicado: (2019)

Virucidal effect against coronavirus SARS-CoV-2 of a silver nanocluster/silica composite sputtered coating
por: Balagna, Cristina, et al.
Publicado: (2020)

Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020
por: Garazzino, Silvia, et al.
Publicado: (2020)

SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
por: Cassaniti, Irene, et al.
Publicado: (2021)

A nosocomial measles outbreak in Italy, February-April 2017
por: Porretta, Andrea, et al.
Publicado: (2017)

Community transmission of monkeypox in the United Kingdom, April to May 2022
por: Vivancos, Roberto, et al.
Publicado: (2022)

The First Italian Telemedicine Program for Non-Critical COVID-19 Patients: Experience from Lodi (Italy)
por: Forlani, Sara, et al.
Publicado: (2022)

Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022
por: Atari, Nofar, et al.
Publicado: (2022)

Reconstructing the impact of COVID-19 on the immunity gap and transmission of respiratory syncytial virus in Lombardy, Italy
por: Ang, Hadrian Jules, et al.
Publicado: (2023)

Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019
por: Stathi, Angeliki, et al.
Publicado: (2019)

Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022
por: Perez Duque, Mariana, et al.
Publicado: (2022)

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
por: Kliker, Limor, et al.
Publicado: (2022)

Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018
por: Broberg, Eeva K, et al.
Publicado: (2018)

SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
por: Oreshkova, Nadia, et al.
Publicado: (2020)

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
por: Lustig, Yaniv, et al.
Publicado: (2021)

Hepatitis A outbreak associated with consumption of dates, England and Wales, January 2021 to April 2021
por: Garcia Vilaplana, Tatiana, et al.
Publicado: (2021)

Emergence of divergent enterovirus (EV) D68 sub-clade D1 strains, northern Italy, September to October 2018
por: Pellegrinelli, Laura, et al.
Publicado: (2019)

Rapid spread of a novel NDM-producing clone of Klebsiella pneumoniae CC147, Northern Italy, February to August 2023
por: Mileto, Irene, et al.
Publicado: (2023)

Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
por: Rovida, F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e0epsobf27nu3u51ujec4t323s